<?xml version="1.0" encoding="UTF-8"?>
<p>On days 0, 1, 3, 5, and 6, clinical examinations were performed on the animals, and respiration rates were determined on anesthetized animals. There was a clear increase in respiration rates in the vehicle-treated animals (
 <xref ref-type="fig" rid="fig02">Fig. 2
  <italic>B</italic>
 </xref>), while respiration rates in prophylactically treated animals remained normal throughout the study. Although respiration rate was increased in therapeutically treated animals at 1 dpi, respiration was statistically significantly lower than in vehicle-treated controls at 3 and 6 dpi (
 <xref ref-type="fig" rid="fig02">Fig. 2
  <italic>B</italic>
 </xref>). On examination days, radiographs were collected from all animals and analyzed for the presence of infiltrates; from 3 dpi onward, lung infiltrates became visible on X-ray (
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1922083117/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Fig. S1
 </ext-link>). At 6 dpi, there was statistically significantly less infiltration in the lungs of animals treated both prophylactically and therapeutically with remdesivir as compared to vehicle-treated control animals (
 <xref ref-type="fig" rid="fig02">Fig. 2
  <italic>C</italic>
 </xref>).
</p>
